KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Capital Expenditures (2016 - 2026)

Eli Lilly filings provide 18 years of Capital Expenditures readings, the most recent being $2.3 billion for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 54.04% to $2.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.7 billion, a 55.1% increase, with the full-year FY2025 number at $7.8 billion, up 55.02% from a year prior.
  • Capital Expenditures hit $2.3 billion in Q1 2026 for Eli Lilly, down from $2.5 billion in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.5 billion in Q4 2025 to a low of $365.4 million in Q1 2022.
  • Median Capital Expenditures over the past 5 years was $1.1 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Capital Expenditures: decreased 2.7% in 2022 and later surged 113.9% in 2023.
  • Eli Lilly's Capital Expenditures stood at $500.7 million in 2022, then surged by 113.9% to $1.1 billion in 2023, then skyrocketed by 39.7% to $1.5 billion in 2024, then soared by 70.21% to $2.5 billion in 2025, then dropped by 8.67% to $2.3 billion in 2026.
  • The last three reported values for Capital Expenditures were $2.3 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.1 billion (Q3 2025) per Business Quant data.